针对瘤的类药物联合体的创新设计概念:对新兴应用的洞察
Ruirong Tan1, Zhenya Yang2, Jun Xie3,4
1Translational Chinese Medicine Key Laboratory of Sichuan, Sichuan-Chongqing Joint Key Laboratory of Innovation of New Drugs of Traditional Chinese Medicine, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan 610041, China.
Chinese medical journal
|March 4, 2025
概括
类药物合物 (PDCs) 提供了增强的癌症治疗,降低了毒性. 本综述涵盖了PDC在瘤学的进展,应用和未来方向.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物结合化学 生物结合化学
背景情况:
- 类药物合物 (PDCs) 在向癌症治疗方面取得了重大进展.
- 与抗体-药物合物 (ADC) 和小分子-药物合物 (SMDC) 相比,PDCs具有优势,包括较低的免疫性,更好的瘤透和更简单的合成.
研究的目的:
- 提供关于类药物联合体 (PDC) 开发当前进展的全面概述.
- 讨论PDC设计,定位,链接器和配方的最新进展.
- 探索PDC在癌症治疗中的日益扩大的临床应用和局限性.
主要方法:
- 关于类药物联合体的最新科学文献的综述.
- 分析PDC设计策略,包括选和链接技术.
- 对PDC疗效和安全的临床数据和临床前研究的评估.
主要成果:
- 与传统治疗相比,PDCs显示出更好的治疗疗效和降低毒性.
- 新型基向机制和先进的链接器化学增强了PDC性能.
- 配方改进对于增加PDC稳定性和生物可用性至关重要.
结论:
- 类药物合物是各种癌症的有前途的治疗方式.
- 对PDC设计和临床评估的持续研究将扩大其在瘤学中的作用.
- 解决目前的局限性将进一步优化基于PDC的癌症疗法.
更多相关视频
05:55Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles
Published on: September 18, 2018
8.7K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461